Monday, 21. June 2010 |
PARI LC SPRINT: nebuliser of choice for clinical trials with inhaled antibiotic
The main advantage of inhaled antibiotic therapy is that the drug directly reaches the site of action and reduces adverse events for the entire organism. Recent results from ongoing clinical trials with ciprofloxacin – an...
[more]
Monday, 21. June 2010 |
Comparison of four portable jet nebuliser systems: PARI BOY® mobile S performed best
In vitro tests revealed significant advantages of the lightweight PARI BOY® mobile S. Compared to the other systems, PARI BOY® mobile S produced more respirable droplets for inhalation into the deep lungs and nebulised the test...
[more]
Wednesday, 16. June 2010 |
See the PARI SINUS in action at the ECFC!
The nasopharyngeal cavity is of particular concern for CF patients as a possible portal of entry for pathogens. This is why a therapy with the PARI SINUS is of special importance!
[more]